micro News and Research

RSS

Agilent collaborates with Baylor College of Medicine to provide CGH microarrays to researchers

Agilent Technologies Inc. has announced it is collaborating with Baylor College of Medicine's Medical Genetics Laboratories to provide customized CGH (comparative genomics hybridization) microarrays to researchers worldwide. Six new microarray designs unite the power of Baylor's data-rich expertise in genetics research with Agilent's microarray manufacturing capabilities to enable advanced discoveries in cancer and cytogenetics research.

12 Nov 2013

Porvair Sciences launches multi-format mixer for laboratory use

Porvair Sciences has introduced the Co-Mix - an accurate, reliable, compact and simple-to-use multi-format mixer.

From Porvair Sciences Limited 12 Nov 2013

Scientist shows how immune system 'attacks' liver cells during hepatitis by using JunB gene

Viral infections are the primary cause of liver inflammation or hepatitis, affecting hundreds of millions of people all over the world, and they represent a public health problem worldwide.

10 Nov 2013

EKF Diagnostics to introduce upgraded POC analyzer and new sTNFr1 test kit at Medica 2013

EKF, announces it will be premiering two novel diagnostic tests at Medica 2013, 20th to 23rd November, Düsseldorf, Germany.

From EKF Diagnostics 8 Nov 2013

IUSL awarded patent for method for changing perception of skin tone

How someone perceives color is determined by how the item they are looking at scatters and emits light. In August, three City College of New York physicists affiliated with the Institute for Ultrafast Spectroscopy and Lasers (IUSL) were awarded a patent for a method for changing perception of skin tone by applying quantum and optical principles to cosmetic preparations.

6 Nov 2013

Valeant Pharmaceuticals' total revenues increase 74% to $1.54B in Q3 2013

Valeant Pharmaceuticals International, Inc. announces third quarter financial results for 2013. "Despite an unexpected early launch of a generic Retin-A Micro, significant headwinds this quarter from foreign exchange movements, and the demands of a major integration, we managed to beat expectations and position Valeant for a terrific fourth quarter and a strong 2014," stated J. Michael Pearson, chairman and chief executive officer.

31 Oct 2013

Researchers receive grant to develop new device that identifies healthy sperm cells for IVF

The World Health Organization estimates more than 70 million couples worldwide are unable to conceive each year, with close to a third of those cases attributable solely to issues with male fertility-including low sperm count and low sperm motility (a limited ability to swim).

31 Oct 2013

Eliza's Star multi-modal programs address gaps in healthcare

Eliza Corporation ("Eliza"), the pioneer and recognized leader in Health Engagement Management, today announced "Star 2014", a proactive member communication solutions suite that addresses key areas of the Centers for Medicare & Medicaid Services (CMS) Star programs.

30 Oct 2013

Researchers overcome obstacle to using viruses to deliver therapeutic genes

Scientists in The Research Institute at Nationwide Children's Hospital have found a way to overcome one of the biggest obstacles to using viruses to deliver therapeutic genes: how to keep the immune system from neutralizing the virus before it can deliver its genetic payload. In a study published recently in Molecular Therapy, researchers found that giving subjects a treatment to temporarily rid the body of antibodies provides the virus safe passage to targeted cells, allowing it to release a corrective or replacement gene to treat disease.

30 Oct 2013

Sanovas receives patent for Multi-Balloon Catheter for Extravasated Drug Delivery

Sanovas Inc., (www.sanovas.com) a life science technology company focused on developing and commercializing next generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that the United States Patent and Trademark Office issued patent # 8,540,667 for the company's Multi-Balloon Catheter for Extravasated Drug Delivery.

29 Oct 2013

One in six fatal traffic accidents results from drowsy driving, show reports

Many of us make light of that relatively short drive home. But getting behind the wheel when you're sleepy can cost lives and lead to imprisonment and a hefty fine.

29 Oct 2013

Psychosis prediction model could facilitate early intervention

A integrated model has shown “outstanding” ability to predict the transition to psychosis in clinically high-risk patients, report investigators in Schizophrenia Bulletin.

25 Oct 2013

"One-two punch" disables tumors' defenses

An aggressive form of breast cancer known as "triple negative" is very difficult to treat: Chemotherapy can shrink such tumors for a while, but in many patients they grow back and gain resistance to the original drugs.

25 Oct 2013

Researchers develop robots for bridge inspection, mine rescue, aid for blind

Robotic rotorcraft for inspecting bridges and other infrastructure, tools for minimally invasive surgery that guide surgeons by creating 3D maps of internal organs and assistive robots for blind travelers are among seven new Carnegie Mellon University research projects sponsored through the National Robotics Initiative.

25 Oct 2013

Study could enhance process of reprogramming adult cells into embryonic-like stem cells

Bioengineers at the University of California, Berkeley, have shown that physical cues can replace certain chemicals when nudging mature cells back to a pluripotent stage, capable of becoming any cell type in the body.

23 Oct 2013

U of T researchers develop method to screen human stem cells

University of Toronto researchers have developed a method that can rapidly screen human stem cells and better control what they will turn into. The technology could have potential use in regenerative medicine and drug development. Findings are published in this week's issue of the journal Nature Methods.

23 Oct 2013

COPD investigational treatments: an interview with Dr. Tunde Otulana, Senior Vice President, Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc.

Olodaterol is a long-acting beta2-agonist (LABA) bronchodilator delivered via the Respimat® inhaler. It is being investigated as a once daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

21 Oct 2013

European Commission approves updated label of Prevenar 13 for high risk pneumococcal disease

Pfizer Inc. (NYSE:PFE) announced today that the European Commission approved updates to the Summary of Product Characteristics (SmPC) for the company's pneumococcal conjugate vaccine Prevenar 13* (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), regarding its use in certain populations at high risk of pneumococcal disease.

18 Oct 2013

Air pollution hampers fetal growth

Exposure to common air pollutants and traffic during pregnancy significantly increases the risk of restricted fetal growth, even at levels well below those stipulated in current European Union (EU) air-quality directives, according to one of the largest studies of its kind, published in The Lancet Respiratory Medicine.

17 Oct 2013

House dust mite allergy treatment: an interview with Steve Harris, CEO & Co-founder of Circassia

House dust mite allergy is a surprisingly prevalent problem. Something like 27% of the U.S. population and 20% of the European population are what’s called skin-prick test positive for house dust mites, which is a test for sensitivity to allergens to find out if a person is likely to get that allergy.

15 Oct 2013

micro News and Research

Agilent collaborates with Baylor College of Medicine to provide CGH microarrays to researchers

Porvair Sciences launches multi-format mixer for laboratory use

Scientist shows how immune system 'attacks' liver cells during hepatitis by using JunB gene

EKF Diagnostics to introduce upgraded POC analyzer and new sTNFr1 test kit at Medica 2013

IUSL awarded patent for method for changing perception of skin tone

Valeant Pharmaceuticals' total revenues increase 74% to $1.54B in Q3 2013

Researchers receive grant to develop new device that identifies healthy sperm cells for IVF

Eliza's Star multi-modal programs address gaps in healthcare

Researchers overcome obstacle to using viruses to deliver therapeutic genes

Sanovas receives patent for Multi-Balloon Catheter for Extravasated Drug Delivery

One in six fatal traffic accidents results from drowsy driving, show reports

Psychosis prediction model could facilitate early intervention

"One-two punch" disables tumors' defenses

Researchers develop robots for bridge inspection, mine rescue, aid for blind

Study could enhance process of reprogramming adult cells into embryonic-like stem cells

U of T researchers develop method to screen human stem cells

COPD investigational treatments: an interview with Dr. Tunde Otulana, Senior Vice President, Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc.

European Commission approves updated label of Prevenar 13 for high risk pneumococcal disease

Air pollution hampers fetal growth

House dust mite allergy treatment: an interview with Steve Harris, CEO & Co-founder of Circassia

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News